Subscribe to Newsletter

Analytical Science

Discovery & Development Business Practice

Relative viscosity screening of monoclonal antibody formulations at low concentration and viscosity

Viscosizer TD provides automated relative viscosity measurements with high reproducibility at low viscosity, to help identify molecules with abnormally high viscosity-concentration profiles at low sample concentrations as early as possible in the development pipeline

Discovery & Development Quality & Compliance

Language as Quality Control...

| Steven Schultz

... or sonicate until the cockroaches disappear. When writing is central to the job of assuring health, safety, and quality, can you afford to be loose with language prone to misunderstanding? Why take a chance? Here are a few strategies to edit your written work for quality control.

Discovery & Development Analytical Science

Cancer Static Shock

| James Strachan

Are the metrics used to measure cancer drug efficacy inherently flawed?

Discovery & Development Analytical Science

Talking Extractables & Leachables – no more unknowns?

Hear from Kyle D’Silva as he discusses new developments in GC-MS technology for Extractables and Leachables testing

Discovery & Development Analytical Science

Talking Extractables & Leachables testing using Orbitrap based mass spectrometry

Hear from Kate Comstock as she talks about her long experience with extractables testing in pharmaceutical companies

Discovery & Development Analytical Science

Talking Extractables & Leachables with Glaxo Smith Kline

Hear from industry expert Jason Creasey as he discusses the history of extractable and leachable testing

Discovery & Development Analytical Science

Talking Extractables & Leachables with Smithers Rapra

Hear how new developments in analytical technology are providing additional insights into unknown contaminants

Discovery & Development Analytical Science

Solving the challenges of Leachable pharmaceutical impurities using a full analytical portfolio

Extractables and leachable compounds are a complex and ever growing list of pharmaceutical impurities

Discovery & Development Analytical Science

Biopharmaceutical characterization demands advanced detection capabilities

Innovation that takes technology design to the physical limits

Discovery & Development Analytical Science

Biotherapeutic Protein Characterization Challenges: The NIBRT Perspective

NIBRT Principle Investigator Jonathan Bones discusses the challenges involved in biotherapeutic protein characterization.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker